Health Catalyst Inc. (HCAT)
Health Catalyst Statistics
Share Statistics
Health Catalyst has 70.21M shares outstanding. The number of shares has increased by 18.93% in one year.
| Shares Outstanding | 70.21M |
| Shares Change (YoY) | 18.93% |
| Shares Change (QoQ) | 15.39% |
| Owned by Institutions (%) | 85.72% |
| Shares Floating | 66.95M |
| Failed to Deliver (FTD) Shares | 4 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 3.16M, so 4.5% of the outstanding shares have been sold short.
| Short Interest | 3.16M |
| Short % of Shares Out | 4.5% |
| Short % of Float | 4.57% |
| Short Ratio (days to cover) | 5.3 |
Valuation Ratios
The PE ratio is -6.12 and the forward PE ratio is 9.28. Health Catalyst's PEG ratio is 0.14.
| PE Ratio | -6.12 |
| Forward PE | 9.28 |
| PS Ratio | 1.39 |
| Forward PS | 0.6 |
| PB Ratio | 1.17 |
| P/FCF Ratio | 32.88 |
| PEG Ratio | 0.14 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Health Catalyst.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.43, with a Debt / Equity ratio of 1.1.
| Current Ratio | 1.43 |
| Quick Ratio | 1.43 |
| Debt / Equity | 1.1 |
| Debt / EBITDA | -14.84 |
| Debt / FCF | 31.08 |
| Interest Coverage | -4.09 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $204.39K |
| Profits Per Employee | $-46.33K |
| Employee Count | 1,500 |
| Asset Turnover | 0.36 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 333K |
| Effective Tax Rate | -0.48% |
Stock Price Statistics
The stock price has increased by -36.77% in the last 52 weeks. The beta is 1.44, so Health Catalyst's price volatility has been higher than the market average.
| Beta | 1.44 |
| 52-Week Price Change | -36.77% |
| 50-Day Moving Average | 4.31 |
| 200-Day Moving Average | 6.59 |
| Relative Strength Index (RSI) | 45.67 |
| Average Volume (20 Days) | 759.24K |
Income Statement
In the last 12 months, Health Catalyst had revenue of 306.58M and earned -69.5M in profits. Earnings per share was -1.15.
| Revenue | 306.58M |
| Gross Profit | 140.78M |
| Operating Income | -69.81M |
| Net Income | -69.5M |
| EBITDA | -27.1M |
| EBIT | -68.53M |
| Earnings Per Share (EPS) | -1.15 |
Balance Sheet
The company has 249.65M in cash and 402.26M in debt, giving a net cash position of -152.62M.
| Cash & Cash Equivalents | 249.65M |
| Total Debt | 402.26M |
| Net Cash | -152.62M |
| Retained Earnings | -1.19B |
| Total Assets | 858.93M |
| Working Capital | 139.8M |
Cash Flow
In the last 12 months, operating cash flow was 14.56M and capital expenditures -15.89M, giving a free cash flow of 12.94M.
| Operating Cash Flow | 14.56M |
| Capital Expenditures | -15.89M |
| Free Cash Flow | 12.94M |
| FCF Per Share | 0.22 |
Margins
Gross margin is 45.92%, with operating and profit margins of -22.77% and -22.67%.
| Gross Margin | 45.92% |
| Operating Margin | -22.77% |
| Pretax Margin | -22.56% |
| Profit Margin | -22.67% |
| EBITDA Margin | -8.84% |
| EBIT Margin | -22.77% |
| FCF Margin | 4.22% |
Dividends & Yields
HCAT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for HCAT is $6.5, which is 62.9% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.5 |
| Price Target Difference | 62.9% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
Scores
| Altman Z-Score | -1.3 |
| Piotroski F-Score | 4 |